Your browser doesn't support javascript.
loading
How does a family history of psychosis influence the risk of methamphetamine-related psychotic symptoms: Evidence from longitudinal panel data.
McKetin, Rebecca; Clare, Philip J; Castle, David; Turner, Alyna; Kelly, Peter J; Lubman, Dan I; Arunogiri, Shalini; Manning, Victoria; Berk, Michael.
Affiliation
  • McKetin R; National Drug and Alcohol Research Centre, University of New South Wales, Sydney, Australia.
  • Clare PJ; National Drug and Alcohol Research Centre, University of New South Wales, Sydney, Australia.
  • Castle D; Prevention Research Collaboration, School of Public Health, University of Sydney, Camperdown, Australia.
  • Turner A; Charles Perkins Centre, University of Sydney, Camperdown, Australia.
  • Kelly PJ; Centre for Addiction and Mental Health and Department of Psychiatry, University of Toronto, Toronto, Canada.
  • Lubman DI; Deakin University, IMPACT Institute for Innovation in Physical and Mental Health and Clinical Translation, School of Medicine, Geelong, Australia.
  • Arunogiri S; School of Psychology and Illawarra Health and Medical Research Institute, University of Wollongong, Wollongong, Australia.
  • Manning V; Monash Addiction Research Centre, Eastern Health Clinical School, Faculty of Medicine, Nursing and Health Sciences, Monash University, Melbourne, Australia.
  • Berk M; Turning Point, Eastern Health, Richmond, Australia.
Addiction ; 118(10): 1975-1983, 2023 10.
Article de En | MEDLINE | ID: mdl-37157055
ABSTRACT

AIMS:

To determine whether the risk of psychotic symptoms during weeks of methamphetamine use was dependent on, increased by, or independent of having a family history of psychosis.

DESIGN:

Secondary analysis of 13 contiguous 1-week periods of data (1370 weeks). A risk modification framework was used to test each scenario.

SETTING:

Geelong, Wollongong and Melbourne, Australia.

PARTICIPANTS:

Participants in a randomized controlled trial of treatment for methamphetamine dependence (n = 148) who did not have a primary psychotic disorder on enrolment. MEASUREMENTS Psychotic symptoms in the previous week were defined as a score of 3+ on any of the Brief Psychiatric Rating Scale items of hallucinations, unusual thought content or suspiciousness. Any (vs no) methamphetamine use in the previous week was assessed using the Timeline Followback method. Self-reported family history of psychosis was assessed using the Diagnostic Interview for Psychosis.

FINDINGS:

The risk of psychotic symptoms in the past week was independently associated with methamphetamine use in that week (relative risk [RR] = 2.3, 95% CI = 1.3-4.3) and with having a family history of psychosis (RR = 2.4, 95% CI = 0.9-7.0); the joint risk among participants with a family history of psychosis during weeks when they were using methamphetamine was large (RR = 4.0, 95% CI = 2.0-7.9). There was no significant interaction between a family history of psychosis and methamphetamine use in predicting psychotic symptoms (interaction RR = 0.7 95% CI = 0.3-1.8), but there was a small non-significant excess risk due to the interaction (0.20 95% CI = -1.63 to 2.03).

CONCLUSIONS:

Among people dependent on methamphetamine, the relative risk of psychotic symptoms during weeks of methamphetamine use does not appear to be dependent on, or increased by, having a family history of psychosis. However, a family history of psychosis does appear to be an independent risk factor that contributes to the absolute risk of psychotic symptoms in this population.
Sujet(s)
Mots clés

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Psychoses toxiques / Troubles psychotiques / Troubles liés aux amphétamines / Métamfétamine Type d'étude: Clinical_trials / Diagnostic_studies / Etiology_studies / Prognostic_studies / Risk_factors_studies Limites: Humans Langue: En Journal: Addiction Sujet du journal: TRANSTORNOS RELACIONADOS COM SUBSTANCIAS Année: 2023 Type de document: Article Pays d'affiliation: Australie

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Psychoses toxiques / Troubles psychotiques / Troubles liés aux amphétamines / Métamfétamine Type d'étude: Clinical_trials / Diagnostic_studies / Etiology_studies / Prognostic_studies / Risk_factors_studies Limites: Humans Langue: En Journal: Addiction Sujet du journal: TRANSTORNOS RELACIONADOS COM SUBSTANCIAS Année: 2023 Type de document: Article Pays d'affiliation: Australie